Results 221 to 230 of about 439,918 (309)
ABSTRACT Background Unfractionated heparin (UFH) remains the standard anticoagulant during percutaneous coronary intervention (PCI), with guidelines recommending a target activated clotting time (ACT) of ≥250 s. However, despite receiving a standardized bolus dose, many patients fail to achieve this target.
Manh Cuong Vu +9 more
wiley +1 more source
Severe and Reversible Left Ventricular Dysfunction Due to Slow Atrial Tachycardia Masquerading as Sinus Tachycardia. [PDF]
Alhaj E, Alhaj D, Alhaj A, Hunt J.
europepmc +1 more source
ABSTRACT Background Chronic thromboembolic pulmonary disease (CTEPD) leads to chronic total occlusions (CTOs) of the pulmonary arteries in a minority of patients. Treatment of CTOs with balloon pulmonary angioplasty (BPA) may substantially improve patient hemodynamics but presents unique technical challenges and has previously been associated with a ...
Elliot J. Stein +4 more
wiley +1 more source
Survival outcomes and predictors following coronary artery bypass grafting in patients with preoperative left ventricular dysfunction. [PDF]
He JM +7 more
europepmc +1 more source
ABSTRACT Sinus venosus defect (SVD) is a rare congenital heart anomaly characterised by an abnormal communication between the atria, often associated with partial anomalous pulmonary venous connection (PAPVC). Traditional surgical repair carries significant risks, prompting exploration into less invasive transcatheter approaches.
Alberto Fuensalida +7 more
wiley +1 more source
ABSTRACT Neonates with infracardiac total anomalous pulmonary venous connection (TAPVC) frequently require urgent treatment. If surgical repair is contraindicated due to extreme prematurity, interventional stenting of the ductus venosus (DV) has been introduced successfully to postpone surgery.
Simon Schmid +4 more
wiley +1 more source
Clinical implications of progressive systemic ventricular dysfunction in adults with Fontan palliation. [PDF]
Bai M +5 more
europepmc +1 more source
ABSTRACT Background Atrial fibrillation (AF) is a frequent comorbidity in patients with severe aortic valve stenosis undergoing transcatheter aortic valve implantation (TAVI). In addition, new‐onset AF can occur after TAVI. However, data on how AF affects outcomes in patients undergoing TAVI remain conflicting.
Kimberley I. Hemelrijk +23 more
wiley +1 more source
The Right Approach: Power of Biomarkers in the Assessment and Management of Right Ventricular Dysfunction. [PDF]
Viduljević M +12 more
europepmc +1 more source
ABSTRACT Background The residual Gensini score (rGS) was developed to quantify the severity of coronary atheroma burden after coronary revascularisation. The predictive value of the rGS for clinical outcomes in patients with ST‐segment elevation myocardial infarction (STEMI) remains unexplored.
Batric Popovic +8 more
wiley +1 more source

